|
Symbol |
Object Name |
Qualifiers
|
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G
|
Ace
|
angiotensin I converting enzyme
|
multiple interactions increases activity
|
EXP
|
[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ACE protein; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACE protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ACE protein]; naringin inhibits the reaction [bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACE protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of ACE protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACE protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of ACE protein]
|
CTD |
PMID:32172062 PMID:32810514 PMID:34797181 PMID:37718616 PMID:38029875 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
|
|
G
|
Ache
|
acetylcholinesterase
|
increases expression multiple interactions increases activity
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of ACHE protein [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in increased expression of ACHE protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ACHE protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of ACHE protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in increased expression of ACHE protein; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of ACHE protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ACHE protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of ACHE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ACHE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of ACHE protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased expression of ACHE protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32772714 PMID:32810514 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions increases expression
|
ISO EXP
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of ACTA2 mRNA]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of ACTA2 mRNA; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of ACTA2 protein bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of ACTA2 mRNA]
|
CTD |
PMID:37718616 PMID:38282657 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G
|
Ada
|
adenosine deaminase
|
multiple interactions increases activity
|
EXP
|
[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ADA protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088
|
|
G
|
Adm
|
adrenomedullin
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of ADM mRNA
|
CTD |
PMID:16040721 |
|
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
|
|
G
|
Agt
|
angiotensinogen
|
multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester inhibits the reaction [AGT protein results in increased activity of PARP1 protein]
|
CTD |
PMID:15502880 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
|
|
G
|
Agtr1b
|
angiotensin II receptor, type 1b
|
increases expression multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of AGTR1B protein Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of AGTR1B protein]; tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of AGTR1B protein]
|
CTD |
PMID:32479886 |
|
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:102,844,969...102,920,232
|
|
G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
multiple interactions decreases expression
|
ISO
|
ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of ALCAM protein]
|
CTD |
PMID:34995009 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:48,336,169...48,537,954
|
|
G
|
Alkbh5
|
alkB homolog 5, RNA demethylase
|
multiple interactions increases expression increases response to substance
|
ISO
|
ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of ALCAM protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of CTNNB1 protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of MYC protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of PPARG protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of VIM protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CDH1 protein]; ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of ENG protein] NG-Nitroarginine Methyl Ester results in increased expression of ALKBH5 protein ALKBH5 protein results in increased susceptibility to NG-Nitroarginine Methyl Ester
|
CTD |
PMID:34995009 |
|
NCBI chr10:45,844,411...45,865,853
Ensembl chr10:45,343,395...45,366,331
|
|
G
|
Atf3
|
activating transcription factor 3
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of ATF3 mRNA]; [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of ATF3 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of ATF3 mRNA; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of ATF3 protein
|
CTD |
PMID:38282657 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
|
|
G
|
Bche
|
butyrylcholinesterase
|
multiple interactions increases activity
|
EXP
|
[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased activity of BCHE protein; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased activity of BCHE protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of BCHE protein]
|
CTD |
PMID:32172062 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
|
|
G
|
Becn1
|
beclin 1
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA]
|
CTD |
PMID:38705399 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
EXP
|
[NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in decreased expression of CASP9 protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of CASP9 protein; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CASP9 protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of CASP9 protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CASP9 protein]; NG-Nitroarginine Methyl Ester inhibits the reaction [bisphenol A results in increased expression of CASP9 protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G
|
Cat
|
catalase
|
multiple interactions decreases activity
|
EXP
|
bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of CAT protein]; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of CAT protein]
|
CTD |
PMID:37718616 PMID:38029875 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
EXP ISO
|
[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 mRNA; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein]]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 mRNA]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of CCL2 protein] [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA]
|
CTD |
PMID:29423081 PMID:38705399 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G
|
Cdh1
|
cadherin 1
|
increases expression multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester results in increased expression of CDH1 protein ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CDH1 protein]
|
CTD |
PMID:34995009 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
|
|
G
|
Celf2
|
CUGBP, Elav-like family member 2
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CELF2 mRNA]; [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CELF2 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CELF2 mRNA; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CELF2 protein
|
CTD |
PMID:38282657 |
|
NCBI chr17:75,813,928...76,639,300
Ensembl chr17:71,210,853...71,728,333
|
|
G
|
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CPEB2 mRNA]; [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CPEB2 protein]
|
CTD |
PMID:38282657 |
|
NCBI chr14:71,999,958...72,056,012
Ensembl chr14:67,787,507...67,840,743
|
|
G
|
Cpeb4
|
cytoplasmic polyadenylation element binding protein 4
|
multiple interactions
|
ISO
|
[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CPEB4 mRNA; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of CPEB4 protein
|
CTD |
PMID:38282657 |
|
NCBI chr10:16,222,271...16,284,248
Ensembl chr10:15,717,794...15,780,603
|
|
G
|
Cst3
|
cystatin C
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
|
|
G
|
Ctnnb1
|
catenin beta 1
|
multiple interactions decreases expression
|
ISO
|
ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of CTNNB1 protein]
|
CTD |
PMID:34995009 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
|
|
G
|
Cybb
|
cytochrome b-245 beta chain
|
increases expression multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein]; tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein]
|
CTD |
PMID:32479886 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of DDIT3 mRNA]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of DDIT3 mRNA
|
CTD |
PMID:38282657 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G
|
Edem3
|
ER degradation enhancing alpha-mannosidase like protein 3
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of EDEM3 mRNA]; [Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of EDEM3 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of EDEM3 mRNA; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of EDEM3 protein
|
CTD |
PMID:38282657 |
|
NCBI chr13:66,403,022...66,470,496
Ensembl chr13:63,858,716...63,920,523
|
|
G
|
Edn1
|
endothelin 1
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of EDN1 mRNA
|
CTD |
PMID:16040721 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
|
|
G
|
Ednra
|
endothelin receptor type A
|
multiple interactions increases expression
|
EXP
|
Atrasentan inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of EDNRA mRNA]
|
CTD |
PMID:34102242 |
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
|
|
G
|
Ednrb
|
endothelin receptor type B
|
decreases expression multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in decreased expression of EDNRB mRNA Atrasentan inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of EDNRB mRNA]
|
CTD |
PMID:34102242 |
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
|
|
G
|
Eng
|
endoglin
|
increases expression multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester results in increased expression of ENG protein ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of ENG protein]
|
CTD |
PMID:34995009 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
|
|
G
|
Fn1
|
fibronectin 1
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of FN1 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of FN1 protein
|
CTD |
PMID:38282657 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
|
|
G
|
Fyn
|
FYN proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Quinolinic Acid results in decreased activity of FYN protein]
|
CTD |
PMID:17265464 |
|
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester promotes the reaction [cupric nitrilotriacetate results in increased activity of GPT protein]
|
CTD |
PMID:36305384 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
decreases activity multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in decreased activity of GPX1 protein bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of GPX1 protein]
|
CTD |
PMID:38029875 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Folic Acid inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]]
|
CTD |
PMID:28624453 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
|
|
G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of HSPA5 mRNA]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of HSPA5 mRNA
|
CTD |
PMID:38282657 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
decreases activity multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in decreased activity of IDH1 protein bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of IDH1 protein]
|
CTD |
PMID:38029875 |
|
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions
|
EXP
|
[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG mRNA; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG protein; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG protein]]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG mRNA]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IFNG protein]
|
CTD |
PMID:29423081 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G
|
Il1a
|
interleukin 1 alpha
|
multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of IL1A mRNA]
|
CTD |
PMID:32142722 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
|
|
G
|
Il1b
|
interleukin 1 beta
|
increases expression multiple interactions
|
EXP ISO
|
NG-Nitroarginine Methyl Ester results in increased expression of IL1B protein [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in increased expression of IL1B protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of IL1B protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in increased expression of IL1B protein; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of IL1B protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of IL1B protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of IL1B protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased expression of IL1B protein] [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 PMID:38705399 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
EXP ISO
|
[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 protein; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 protein]]; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of IL6 mRNA]; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of IL6 protein]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 mRNA]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of IL6 protein] NG-Nitroarginine Methyl Ester results in increased expression of IL6 mRNA; NG-Nitroarginine Methyl Ester results in increased expression of IL6 protein [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA]
|
CTD |
PMID:29423081 PMID:37718616 PMID:38029875 PMID:38705399 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Lama1
|
laminin subunit alpha 1
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of LAMA1 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of LAMA1 protein
|
CTD |
PMID:38282657 |
|
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:107,692,770...107,817,478
|
|
G
|
Lyn
|
LYN proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Quinolinic Acid results in decreased activity of LYN protein]
|
CTD |
PMID:17265464 |
|
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:16,639,466...16,756,868
|
|
G
|
Maoa
|
monoamine oxidase A
|
increases expression multiple interactions increases activity
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of MAOA protein [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in increased expression of MAOA protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of MAOA protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of MAOA protein; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of MAOA protein]; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of MAOA protein]; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased activity of MAOA protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of MAOA protein]; naringin inhibits the reaction [bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of MAOA protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of MAOA protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of MAOA protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of MAOA protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased expression of MAOA protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:6,030,795...6,099,593
|
|
G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
decreases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in decreased expression of MCL1 mRNA
|
CTD |
PMID:36260529 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
|
|
G
|
Mdh2
|
malate dehydrogenase 2
|
multiple interactions decreases activity
|
EXP
|
bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of MDH2 protein]
|
CTD |
PMID:38029875 |
|
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
|
|
G
|
Mir377
|
microRNA 377
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of MIR377]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of MIR377
|
CTD |
PMID:38282657 |
|
NCBI chr 6:134,576,456...134,576,527
|
|
G
|
Mir494
|
microRNA 494
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of MIR494]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of MIR494
|
CTD |
PMID:38282657 |
|
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:128,728,709...128,728,793
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Dibutyl Phthalate results in increased activity of MMP2 protein]
|
CTD |
PMID:38944327 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
|
|
G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester inhibits the reaction [caffeic acid inhibits the reaction [Ethanol results in increased activity of MPO protein]]
|
CTD |
PMID:33301711 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
decreases expression multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester results in decreased expression of MYC protein ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of MYC protein]
|
CTD |
PMID:34995009 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
|
|
G
|
Nfkbib
|
NFKB inhibitor beta
|
multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Arginine inhibits the reaction [Indomethacin results in increased expression of NFKBIB mRNA]]
|
CTD |
PMID:37483153 |
|
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:84,046,295...84,053,862
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein]
|
CTD |
PMID:38705399 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
EXP
|
[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]]; NG-Nitroarginine Methyl Ester inhibits the reaction [Arginine inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 mRNA]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of NOS2 protein]
|
CTD |
PMID:29423081 PMID:37483153 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G
|
Nos3
|
nitric oxide synthase 3
|
decreases expression multiple interactions
|
ISO EXP
|
NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein [Folic Acid co-treated with NG-Nitroarginine Methyl Ester] results in decreased expression of NOS3 protein Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein]; tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein]
|
CTD |
PMID:28624453 PMID:32479886 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
|
|
G
|
Nppa
|
natriuretic peptide A
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of NPPA mRNA
|
CTD |
PMID:16040721 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
|
|
G
|
Nppb
|
natriuretic peptide B
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of NPPB mRNA
|
CTD |
PMID:16040721 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
|
|
G
|
Ogdh
|
oxoglutarate dehydrogenase
|
decreases activity multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in decreased activity of OGDH protein bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of OGDH protein]
|
CTD |
PMID:37718616 PMID:38029875 |
|
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:81,150,091...81,217,479
|
|
G
|
Panx3
|
pannexin 3
|
multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of PANX3 mRNA]
|
CTD |
PMID:32142722 |
|
NCBI chr 8:45,554,474...45,566,378
Ensembl chr 8:37,366,862...37,377,640
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester inhibits the reaction [AGT protein results in increased activity of PARP1 protein]
|
CTD |
PMID:15502880 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Pde5a
|
phosphodiesterase 5A
|
increases activity multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased activity of PDE5A protein [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of PDE5A protein; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of PDE5A protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of PDE5A protein]; naringin inhibits the reaction [bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased activity of PDE5A protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of PDE5A protein]]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of PDE5A protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased activity of PDE5A protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:210,858,063...210,999,701
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions decreases expression
|
ISO
|
ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of PPARG protein]
|
CTD |
PMID:34995009 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO EXP
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Folic Acid inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 mRNA]]; NG-Nitroarginine Methyl Ester inhibits the reaction [Folic Acid inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] NG-Nitroarginine Methyl Ester inhibits the reaction [Arginine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA]]
|
CTD |
PMID:28624453 PMID:37483153 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G
|
Pycard
|
PYD and CARD domain containing
|
multiple interactions
|
ISO
|
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA]
|
CTD |
PMID:38705399 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
|
|
G
|
Ramp2
|
receptor activity modifying protein 2
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of RAMP2 mRNA
|
CTD |
PMID:16040721 |
|
NCBI chr10:86,689,148...86,690,956
Ensembl chr10:86,188,812...86,231,829
|
|
G
|
Ramp3
|
receptor activity modifying protein 3
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of RAMP3 mRNA
|
CTD |
PMID:16040721 |
|
NCBI chr14:85,741,314...85,758,813
Ensembl chr14:81,527,385...81,544,902
|
|
G
|
Sdha
|
succinate dehydrogenase complex flavoprotein subunit A
|
multiple interactions decreases activity
|
EXP
|
bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of SDHA protein]
|
CTD |
PMID:38029875 |
|
NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:28,940,164...28,961,535
|
|
G
|
Setd2
|
SET domain containing 2, histone lysine methyltransferase
|
decreases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in decreased expression of SETD2 mRNA alternative form
|
CTD |
PMID:36260529 |
|
NCBI chr 8:119,390,207...119,475,863
Ensembl chr 8:110,511,772...110,597,489
|
|
G
|
Smad2
|
SMAD family member 2
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased phosphorylation of SMAD2 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased phosphorylation of SMAD2 protein
|
CTD |
PMID:38282657 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
|
|
G
|
Smad3
|
SMAD family member 3
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased phosphorylation of SMAD3 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased phosphorylation of SMAD3 protein
|
CTD |
PMID:38282657 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
|
|
G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions decreases activity
|
EXP
|
bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased activity of SOD1 protein]
|
CTD |
PMID:38029875 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G
|
Spn
|
sialophorin
|
multiple interactions increases expression
|
EXP
|
[NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in decreased expression of SPN protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of SPN protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in decreased expression of SPN protein; bisphenol A inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of SPN protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of SPN protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of SPN protein]
|
CTD |
PMID:32172062 PMID:32428650 |
|
NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:181,746,429...181,759,628
|
|
G
|
Sqstm1
|
sequestosome 1
|
multiple interactions
|
ISO
|
[Berberine co-treated with Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of SQSTM1 protein
|
CTD |
PMID:38705399 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester inhibits the reaction [Quinolinic Acid results in decreased activity of SRC protein]
|
CTD |
PMID:17265464 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions decreases expression
|
EXP
|
Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of STAR protein]; tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of STAR protein]
|
CTD |
PMID:32479886 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
|
|
G
|
Tbxa2r
|
thromboxane A2 receptor
|
increases expression
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of TBXA2R mRNA
|
CTD |
PMID:34102242 |
|
NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:8,383,378...8,388,176
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
ISO
|
[Huang Qi co-treated with Coptidis rhizoma extract co-treated with Aconitic Acid co-treated with Centella asiatica extract] inhibits the reaction [[Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TGFB1 protein]; [Streptozocin co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TGFB1 protein
|
CTD |
PMID:38282657 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G
|
Th
|
tyrosine hydroxylase
|
decreases expression
|
ISO
|
NG-Nitroarginine Methyl Ester results in decreased expression of TH protein
|
CTD |
PMID:31187328 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP ISO
|
[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF mRNA; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of TNF protein; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]]; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TNF mRNA]; bisphenol A promotes the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TNF protein]; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of TNF protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TNF protein]; NG-Nitroarginine Methyl Ester inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein]]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF mRNA]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TNF protein] NG-Nitroarginine Methyl Ester results in increased expression of TNF mRNA; NG-Nitroarginine Methyl Ester results in increased expression of TNF protein [NG-Nitroarginine Methyl Ester co-treated with TNF protein] results in increased secretion of VWF protein [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA]
|
CTD |
PMID:29423081 PMID:30529211 PMID:32172062 PMID:32428650 PMID:32810514 PMID:34678311 PMID:37718616 PMID:38029875 PMID:38705399 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression multiple interactions
|
EXP
|
NG-Nitroarginine Methyl Ester results in increased expression of TP53 protein [bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TP53 protein; [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of TP53 protein; [NG-Nitroarginine Methyl Ester co-treated with naringin] results in decreased expression of TP53 protein; bisphenol A inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TP53 protein]; naringin inhibits the reaction [[bisphenol A co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of TP53 protein]; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased expression of TP53 protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of TP53 protein]; NG-Nitroarginine Methyl Ester promotes the reaction [bisphenol A results in increased expression of TP53 protein]
|
CTD |
PMID:32172062 PMID:32428650 PMID:32810514 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G
|
Trpa1
|
transient receptor potential cation channel, subfamily A, member 1
|
decreases response to substance
|
ISO
|
TRPA1 gene mutant form results in decreased susceptibility to NG-Nitroarginine Methyl Ester
|
CTD |
PMID:32634517 |
|
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
|
|
G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
EXP
|
[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 mRNA; [Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 mRNA]; alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 mRNA]]; alpha-Linolenic Acid inhibits the reaction [Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]]; Particulate Matter inhibits the reaction [alpha-Linolenic Acid inhibits the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 mRNA]; Particulate Matter promotes the reaction [[Cholesterol, Dietary co-treated with NG-Nitroarginine Methyl Ester] results in increased expression of VCAM1 protein]
|
CTD |
PMID:29423081 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
|
|
G
|
Vim
|
vimentin
|
multiple interactions decreases expression
|
ISO
|
ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of VIM protein]
|
CTD |
PMID:34995009 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
|
|
G
|
Vwf
|
von Willebrand factor
|
multiple interactions
|
ISO
|
[NG-Nitroarginine Methyl Ester co-treated with TNF protein] results in increased secretion of VWF protein
|
CTD |
PMID:34678311 |
|
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
|
|
G
|
Wnt2
|
Wnt family member 2
|
decreases expression multiple interactions
|
ISO
|
NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein]
|
CTD |
PMID:34995009 |
|
NCBI chr 4:47,294,300...47,340,284
Ensembl chr 4:46,333,998...46,374,402
|
|